List of Figures
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Tumor Lysis Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 11
Tumor Lysis Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Proportion of Tumor Lysis Syndrome to Metabolic Disorders Clinical Trials, G7 Countries (%), 2018* 15
Tumor Lysis Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Tumor Lysis Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Tumor Lysis Syndrome to Metabolic Disorders Clinical Trials, E7 Countries (%), 2018* 19
Tumor Lysis Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Tumor Lysis Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Tumor Lysis Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
GlobalData Methodology 51


List of Tables
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Region, 2018* 7
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Tumor Lysis Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11
Tumor Lysis Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Tumor Lysis Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Tumor Lysis Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14
Proportion of Tumor Lysis Syndrome to Metabolic Disorders Clinical Trials, G7 Countries (%), 2018* 16
Tumor Lysis Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Tumor Lysis Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Tumor Lysis Syndrome to Metabolic Disorders Clinical Trials, E7 Countries (%), 2018* 20
Tumor Lysis Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Tumor Lysis Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Phase, 2018* 23
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Tumor Lysis Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34